Senate committee prepares to vote on bill to allow sale of medicine in supermarkets

The Senate's Social Affairs Committee (CAS) is scheduled to meet on Wednesday, the 17th, to evaluate a bill that would authorize supermarkets to sell over-the-counter medications . The bill was authored by Senator Efraim Filho (União-PB) and is being reported by Humberto Costa (Workers' Party-PE).
The version presented by Humberto differs from the original. In his proposed report, the Workers' Party member adds the requirement for a fully equipped pharmacy or drugstore to be installed within the supermarket, physically isolated from the rest of the operation. The facility must comply with the health standards of the National Health Surveillance Agency (Anvisa). The politician also requires a pharmacist to be present on-site.
It's worth noting that the matter was already on the committee's agenda on the 10th, but was removed from the list of bills ready for voting following a request from Senator Dr. Hiran (PP-RR). The congressman pointed out that the bill didn't address the development of private label medications. According to the bill's rapporteur, however, there is already an Anvisa regulation prohibiting the development of private label medications by pharmacies and drugstores.
If the bill advances in the Committee, it will still need to receive approval from the full Senate. After that, it will move on to the Chamber of Deputies.
(With information from the Senate Agency)

CartaCapital For 31 years, the greatest progressive reference in journalism in Brazil.
Subscribe to our newsletter and receive an exclusive morning bulletin
After difficult years , we've returned to a Brazil that feels at least a little bit normal. This new normal, however, remains fraught with uncertainty . The Bolsonaro threat persists, and the appetites of the market and Congress continue to pressure the government. Abroad, the global rise of the far right and the brutality in Gaza and Ukraine risk imploding the fragile foundations of global governance.
CartaCapital doesn't receive support from banks or foundations. It survives solely on advertising and project sales, and contributions from its readers . And your support, our readers, is increasingly crucial .
Don't let Carta stop. If you value good journalism, help us keep fighting. Subscribe to the weekly edition of the magazine or contribute whatever you can.
Subscribe to our newsletter and receive an exclusive morning bulletin
CartaCapital